pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

Midterm election outcomes could reshape U.S. health policy, experts say

Oct 31, 2026·read at STAT ↗RegulatoryNeutral

The article notes that regardless of the results, the upcoming midterm elections will have broad effects on the U.S. health system, according to more than two dozen policymakers, lobbyists and experts interviewed by STAT.

If Democrats retain control of Congress, the expectation is slower legislative action and heightened oversight investigations. Conversely, a continued Republican majority could accelerate the party's health related legislative agenda.

The interviewees highlighted several specific areas that could shift, including funding for public health programs, regulatory reforms, and the overall direction of federal health infrastructure.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: What are the health stakes of the midterms? Policymakers, lobbyists, and experts weigh in”

read at STAT ↗
480 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
CardiologyVaccines

related stories

  • Jun 9Opinion: Why STAT is sticking with ‘health care’ as two wordsSTAT
  • Jun 6Opinion: How the Amish think about vaccines, health care costs, and much moreSTAT
  • Jun 5CDC: Ebola outbreak in Central Africa could reach 20,000 cases without strong countermeasuresSTAT
  • Jun 5Senior NIH official pushes MAHA strategy to skeptical ADA audienceSTAT
  • Jun 5Texas AG investigating energy drinksSTAT